The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Servier
Research Funding - Frame Therapeutics (Inst); Lead Pharma (Inst)
Patents, Royalties, Other Intellectual Property - P125052US00 STROMA-TARGETING TREATMENT FOR PATIENTS WITH ELEVATED ADAM12 LEVELS
Travel, Accommodations, Expenses - Servier
Outcome prediction in resectable esophageal adenocarcinoma based on clinical variables, radiomics, and ctDNA.
 
Tom van den Ende
No Relationships to Disclose
 
Steven C. Kuijper
No Relationships to Disclose
 
Yousif Widaatalla
No Relationships to Disclose
 
Wyanne A. Noortman
No Relationships to Disclose
 
Floris H.P. van Velden
No Relationships to Disclose
 
Henry C. Woodruff
No Relationships to Disclose
 
Ymke van der Pol
No Relationships to Disclose
 
Norbert Moldovan
No Relationships to Disclose
 
D. Michiel Pegtel
Leadership - ExBiome
Stock and Other Ownership Interests - ExBiome
Consulting or Advisory Role - Takeda Science Foundation
Research Funding - Prediction Biosciences (Inst)
Patents, Royalties, Other Intellectual Property - Exomes
Travel, Accommodations, Expenses - Takeda
 
Sarah Derks
No Relationships to Disclose
 
Maarten F. Bijlsma
No Relationships to Disclose
 
Florent Moulière
Honoraria - Roche
Patents, Royalties, Other Intellectual Property - Cancer Research UK Technologies
 
Lioe-Fee de Geus-Oei
No Relationships to Disclose
 
Philippe Lambin
No Relationships to Disclose
 
Hanneke W.M. Van Laarhoven
Consulting or Advisory Role - Astellas Pharma (Inst); Bristol-Myers Squibb; Dragonfly Therapeutics; Merck; Novartis (Inst); Servier
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca